Doxepin Hydrochloride Tablet
Product Images NDC 44183-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 44183-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Currax Pharmaceuticals Llc Dba Cypress, Hawthorn, Macoven, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxepin 01)

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

This is a prescription medication called Doxepin HCI Tablets. Each tablet contains 3.39 mg of doxepin hydrochloride, which is equivalent to 3mg of doxepin. It is important to keep this medication out of reach of children and to provide each patient with the accompanying Medication Guide. The tablets should be stored in a tight, light-resistant container at controlled room temperature (20°-25°C/ 68°-77°F). This product is distributed by Macoven, located in Brentwood, TN. The prescribing information for this medication is available and should be consulted before use.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Doxepin HCI Tablets is a prescription medicine containing 6.78 mg doxepin hydrochloride, equivalent to 6 mg of doxepin per tablet. Each bottle of Doxepin HCI Tablets contains 30 tablets and a medication guide should be dispensed to each patient. The medication should be stored at room temperature in a tight, light-resistant container and out of reach of children. For information about the dosage and use, please refer to the accompanying Prescribing Information. Distributed by Macoven in Brentwood, TN.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.